Ben Bronstein - 10 Jun 2025 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
Director
Signature
/s/ Ben Bronstein
Issuer symbol
ALDX
Transactions as of
10 Jun 2025
Transactions value $
$0
Form type
4
Filing time
12 Jun 2025, 16:29:02 UTC
Previous filing
06 Jun 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bronstein Ben Director C/O ALDEYRA THERAPEUTICS, INC., 131 HARTWELL AVENUE, LEXINGTON /s/ Ben Bronstein 12 Jun 2025 0001604458

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALDX Stock Option (Right to Buy) Award $0 +62.7K $0.00 62.7K 10 Jun 2025 Common Stock 62.7K $2.69 Direct F1
transaction ALDX Stock Option (Right to Buy) Award $0 +3.62K $0.00 3.62K 10 Jun 2025 Common Stock 3.62K $2.69 Direct F2
transaction ALDX Stock Option (Right to Buy) Award $0 +3.86K $0.00 3.86K 10 Jun 2024 Common Stock 3.86K $2.69 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
F2 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.
F3 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.